Calluna Pharma vs Vigil Neuroscience

Calluna Pharma logo

Calluna Pharma

Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source

27 employees · est. 2024 · Oslo, Norway

VS
Vigil Neuroscience logo

Vigil Neuroscience

Harnessing the power of microglia to transform treatments for neurodegenerative diseases

76 employees · est. 2020 · Watertown, United States

Vigil Neuroscience is the older company (2024 vs 2020); Vigil Neuroscience is the larger of the two.

Side-by-Side Comparison

Calluna Pharma Vigil Neuroscience
Founded
2024 2020 older
Headquarters
Oslo, Norway Watertown, United States
Employees
27 76 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Series A Acquired
Total Funding
$75.00M $650.00M
Funding Rounds
1 5
Services
development of first-in-class clinical-stage antibodies, research and development in fibrosis and inflammation, pharmaceutical innovation Not tracked yet
Target Customers
patients with high unmet medical needs related to fibrosis and inflammation, healthcare providers, medical institutions Not tracked yet
Taxonomy
Chronic InflammationFibrosisTherapiesClinical StageBiotechUpstream Amplifiers +9 Neurodegenerative DiseasesMicrogliaClinical-stageTherapeutic ModalitiesPrecision-based TherapiesMonoclonal Antibodies +8
Website
callunapharma.com vigilneuro.com
Calluna Pharma logo

About Calluna Pharma

Calluna Pharma, founded in 2024, is a clinical-stage biotech company based in Norway. The company focuses on developing first-in-class therapies to address chronic inflammation and fibrosis by targeting the upstream amplifiers of diseases. This innovative approach could potentially yield treatments...

Vigil Neuroscience logo

About Vigil Neuroscience

Vigil Neuroscience is a clinical-stage biotechnology company established in 2020 with a focus on developing treatments for neurodegenerative diseases. The company's slogan, "Harnessing the power of microglia to transform treatments for neurodegenerative diseases," underlines its innovative approach....

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Calluna Pharma and Vigil Neuroscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Calluna Pharma or Vigil Neuroscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Calluna Pharma was founded in 2024, based in Oslo, Norway, with 27 employees. Calluna Pharma, founded in 2024, is a clinical-stage biotech company based in Norway. The company focuses on developing first-in-class therapies to address chronic inflammation and fibrosis by targeti. Vigil Neuroscience was founded in 2020, based in Watertown, United States, with 76 employees. Vigil Neuroscience is a clinical-stage biotechnology company established in 2020 with a focus on developing treatments for neurodegenerative diseases. The company's slogan, "Harnessing the power of mi.
Calluna Pharma has raised $75.00M and Vigil Neuroscience $650.00M. Latest stage: Calluna Pharma Series A, Vigil Neuroscience Acquired.
Both work in Biotechnology.

Compare Calluna Pharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Calluna Pharma on 25 Mar 2026, and Vigil Neuroscience on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes